Tradestie Institutional Equity Comparison Engine
INCR vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INCR Overall Edge
INCR Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Intercure Ltd. Ordinary Shares (INCR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INCR trades at 6.2x Forward P/E with 0.0% operating margin (+23.9% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, INCR sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
INCR
INCR 6.2x vs BHST N/M Fwd P/E
Growth & Margin Winner
INCR
Op Margin 0.0% vs -18.0% ยท YoY +23.9% vs +3.8%
Momentum & Technical Winner
INCR
1Y +136.7% vs -79.4% ยท 52W Pos 47% vs 6%
Options & Structure Winner
INCR
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
INCR
NASDAQ
Intercure Ltd. Ordinary Shares
Pharmaceutical Preparations
$3.24
-7.16% 1D
Market Cap
$45.5M
1M Return
-26.86%
1Y Return
+136.67%
Forward P/E
6.2x
Unified AI Score
66.8 / 100
BUY
Tech 68.0
Fund 62.0
Flow 58.0
Mom 60.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
INCR +136.67%
BHST -79.4%
Spread: +221.19 pp (INCR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
INCR TTM Op. Margin: 0.0%
BHST TTM Op. Margin: -18.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INCR vs BHST. Trailing 12-month operating profitability (INCR 0.0% vs BHST -18.0%) and valuation multiples (INCR 6.2x vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | INCR | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $45.5M | $29.9M | Larger Scale | INCR |
| Trailing P/E Ratio Valuation | 6.2x | N/M | Lower Multiple | INCR |
| Forward P/E Ratio Valuation | 6.2x | N/M | Lower Multiple | INCR |
| Revenue Growth (YoY) Growth | +23.9% | +3.8% | Higher Growth | INCR |
| Operating Margin (TTM) Profitability | 0.0% | -18.0% | Higher Margin | INCR |
| Net Profit Margin Profitability | -13.2% | -31.2% | Higher Margin | INCR |
| Return on Equity (ROE) Capital Efficiency | -9.3% | -142.5% | Higher ROE | INCR |
| 52-Week Range Position Momentum | 47% ($1โ$6) | 6% ($1โ$7) | Stronger Trend | INCR |
| Beta / 30D Volatility Risk Regime | 0.07ฮฒ ยท 80% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | INCR |
| Unified Institutional Score Composite Signal | 66.8 / 100 (BUY) | 58.2 / 100 (HOLD) | Higher Composite | INCR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full INCR vs BHST Buy Guide
INCR
BREAKDOWN
59d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither INCR nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.